Filing Details
- Accession Number:
- 0001209191-17-053206
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-18 17:46:46
- Reporting Period:
- 2017-09-15
- Accepted Time:
- 2017-09-18 17:46:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604464 | Atara Biotherapeutics Inc. | ATRA | Biological Products, (No Disgnostic Substances) (2836) | 460920988 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612095 | Christopher Haqq | 611 Gateway Boulevard Suite 900 South San Francisco CA 94080 | Evp, R&D & Chief Scientific Of | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-09-15 | 6,000 | $15.30 | 349,305 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 17,312 | Indirect | See footnote |
| Common Stock | 2,688 | Indirect | See footnote |
Footnotes
- Transaction pursuant to Rule 10b5-1 Plan adopted September 27, 2016.
- The shares are held by the Chris Haqq 2014 GRAT, of which the Reporting Person is trustee.
- The shares are held by The Havenside Trust, of which the Reporting Person is trustee.
Billionaire Hedge Funds
